Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 29;16(3):e0249298.
doi: 10.1371/journal.pone.0249298. eCollection 2021.

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment

Affiliations

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment

Sven van Egmond et al. PLoS One. .

Abstract

Background: Follow-up after low-risk basal cell carcinoma (BCC) is being provided more frequently than recommended by guidelines. To design an acceptable strategy to successfully reduce this 'low-value' care, it is important to obtain insights into the preferences of patients and dermatologists.

Objective: To determine the preferences and needs of patients and dermatologists to reduce low-risk BCC follow-up care, and the trade-offs they are willing to make.

Methods: A questionnaire including a discrete choice experiment was created, containing attributes regarding amount of follow-up, continuity of care, method of providing addition information, type of healthcare provider, duration of follow-up visits and skin examination. In total, 371 BCC patients and all Dutch dermatologists and dermatology residents (n = 620) were invited to complete the questionnaire. A panel latent class model was used for analysis.

Results: Eighty-four dermatologists and 266 BCC patients (21% and 72% response rates respectively) completed the discrete choice experiment. If the post-treatment visit was performed by the same person as treatment provider and a hand-out was provided to patients containing personalised information, the acceptance of having no additional follow-up visits (i.e. following the guidelines) would increase from 55% to 77% by patients. Female patients and older dermatologists, however, are less willing to accept the guidelines and prefer additional follow-up visits.

Limitations: The low response rate of dermatologists.

Conclusion: This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.

PubMed Disclaimer

Conflict of interest statement

We understand that VGZ must be explicitly mentioned as a commercial funder. We would like to alter our Competing Interest Statement to: “The authors and funders (Dutch Ministry of Health, Welfare and Sport and the health insurance company VGZ) have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Choice task example of the discrete choice experiment.
Fig 2
Fig 2. Expected patient choice probabilities of different BCC follow-up scenarios based on latent class model.
*standard post-treatment visits performed by a different person than treatment provider, extra information provided by a general handout, two additional follow-up visits in a year conducted by a dermatologist and a ten minute consultation in which the face, upper body and treated area are checked.

Similar articles

Cited by

References

    1. Flohil SC, Koljenovic S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol. 2011;165(4):874–81. Epub 2011/06/30. 10.1111/j.1365-2133.2011.10488.x - DOI - PubMed
    1. Marzuka AG, Book SE. Basal Cell Carcinoma: Pathogenesis, Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management. Yale J Biol Med 2015;88(2):: 167–79. - PMC - PubMed
    1. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. British Journal of Dermatology. 2017. 10.1111/bjd.15321 - DOI - PubMed
    1. Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP). 2015;24(2):141–9. Epub 2014/08/05. 10.1097/CEJ.0000000000000056 - DOI - PubMed
    1. Leavitt M. Medscape’s response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century. MedGenMed: Medscape general medicine. 2001;3(2):2. Epub 2001/09/11. - PubMed